Immunotech Biopharm Ltd

06978

Company Profile

  • Business description

    Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.

  • Contact

    No.1 Kangding Street
    8th Floor, Block 1, Guosheng Technology Park
    Beijing Economic-technological Development Area
    Beijing100176
    CHN

    T: +86 8610884002

    https://www.eaal.net

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    154

Stocks News & Analysis

stocks

Wildly overvalued ASX stock is skating on thin ice

This company dominates its industry and could be flirting with regulatory intervention.
stocks

Uber flexes its network effect and delivers strong result

Uber’s business is humming along but autonomous vehicles add uncertainty to the longer term outlook.
stocks

Ask the analyst: Are Qantas shares a value trap?

Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,098.3012.80-0.14%
CAC 407,635.0313.990.18%
DAX 4023,924.3678.290.33%
Dow JONES (US)44,193.1281.380.18%
FTSE 1009,164.3121.580.24%
HKSE25,051.16140.530.56%
NASDAQ21,169.42252.871.21%
Nikkei 22541,032.65237.790.58%
NZX 50 Index12,887.106.940.05%
S&P 5006,345.0645.870.73%
S&P/ASX 2008,828.1015.60-0.18%
SSE Composite Index3,640.556.560.18%

Market Movers